From the New England Journal of Medicine
Improving health care for all is an important priority. One persistent issue involves the lack of data to guide cancer care for older adults. Although clinical trials provide the strongest foundation for acquiring such data, a recent analysis by the Food and Drug Administration (FDA) found that only 24% of patients enrolled in trials supporting oncology-drug approvals were 70 years of age or older, compared with the 42% of such patients in the Surveillance, Epidemiology, and End Results database who would be eligible to receive the treatments after they were approved.
Link
